Stay updated on Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.

Latest updates to the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page
- Check5 days agoChange DetectedRecord History now includes an administrative closure and termination, with new entries indicating Results Posted and updated study sections. Added sections cover Adverse Events, Baseline Characteristics, Outcome Measures, Participant Flow, and other core documentation.SummaryDifference2%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Record History now includes a new revision entry (v3.5.3) and removes the prior revision (v3.5.2). This reflects an update to the study record's revision metadata.SummaryDifference0.1%

- Check27 days agoChange DetectedThe number of “Results Submission Events” shown in the record history increased from 3 to 4, reflecting an additional results-submission event entry. This does not indicate a change to the substantive study details themselves.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision v3.5.2 was added to the history and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded 'Results Submission Events (3)' and 'Revision: v3.5.0' to the Record History. Removed 'Results Submission Events (2)' and 'Revision: v3.4.3'.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3 to reflect a UI/system update.SummaryDifference0.1%

Stay in the know with updates to Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vodobatinib for Ph+ CML: Safety & Efficacy Clinical Trial page.